Markus Warmuth

President & CEO

Markus Warmuth (President & CEO) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Monte Rosa Therapeutics, Inc. (GLUE). The largest single filing was $220K of GLUE (9,500 sh × $23.18, as filed), executed Jul 16.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$619K

shares × price, as filed

Last traded

Jul 16

Filed Jul 17

Median ADV $21.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $619K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

GLUE

Monte Rosa Therapeutics, Inc. GLUE · 0 buys · 4 sells 4 filings

Recent filings

GLUESALE Monte Rosa Therapeutics, Inc. View filing → $220K
9,500 sh × $23.18
Exec Jul 16
Filed Jul 17 · 4:05 PM ET GLUESALE Monte Rosa Therapeutics, Inc. View filing → $103K
5,467 sh × $18.92
Exec May 1
Filed May 5 · 5:30 PM ET GLUESALE Monte Rosa Therapeutics, Inc. View filing → $141K
8,000 sh × $17.64
Exec Apr 14
Filed Apr 15 · 5:30 PM ET GLUESALE Monte Rosa Therapeutics, Inc. View filing → $154K
10,135 sh × $15.17
Exec Jan 5
Filed Jan 5 · 5:30 PM ET